Birkbeck University of London
Peter is a social science researcher and currently teaches at Birkbeck University of London. The nature of his research means that he regularly collaborates with healthcare managers, doctors and other allied healthcare professionals. His research is centered around how best to implement and assimilate healthcare initiatives. In particular, Peter is interested in the impact of
blame cultures on organisational learning and performance and the processes surrounding decision making within healthcare organisations. Recently, Peter has contributed to the debate on improving patient safety through the publication of his research findings in the Westminster Health Forum and advised NHS England with regard to the design and development of the
recent national NHS England core patient experience survey questionnaire questions. Peter regularly presents his research at national and international meetings and has published on medical engagement, blame culture and clinical guideline adoption in the academic literature.
Improving Quality of Diagnostic PET-CT Reporting: Factors Influencing Doctors’ Performance.
The seminar provides a unique overview of standards of diagnostic reporting in PET-CT in England between 2010 to 2016. By empirically measuring rates of discrepancy and correlating it to the results of attitudinal survey data, the findings shed light on the factors to influence clinical performance and in particular the association between the level of doctors’ engagement and
EVEN MORE SEMINARS
Prof Adam Waldman MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging
Biomarkers in Adult Glioma
Dr Sam Hare Royal Free London NHS Foundation Trust
How I evaluate lung lesions for CT-guided biopsy?
Dr Arjun Nair The Harley Street Clinic (Part of HCA healthcare UK)
Advance Technologies in Diagnostics
Professor Patricia Price Action Radio Therapy
Action Radiotherapy -a charity for radiotherapy patients and professionals.
Glenn Flux Royal Marsden / Institute of Cancer Research
The emergence and resurgence of radiotherapeutics for cancer treatment